Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Treatment of Children With Insufficient Secretion of Growth Hormone

NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

NCT02724228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess Growth in Children With Idiopathic Short Stature

NCT06309979 ·Status: RECRUITING

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

NCT06668805 ·Status: RECRUITING ·Phase: PHASE2

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03424018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

NCT01603095 ·Status: COMPLETED

Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency

NCT00191165 ·Status: COMPLETED ·Phase: PHASE3

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

NCT01502124 ·Status: COMPLETED ·Phase: PHASE3

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

NCT00705172 ·Status: COMPLETED

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

Versartis Trial in Children to Assess Long-Acting Growth Hormone

NCT01718041 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

NCT00102817 ·Status: COMPLETED ·Phase: PHASE3

Prospective Clinical Assessment Study in Children With Hypochondroplasia

NCT06410976 ·Status: RECRUITING

Extension Study of Infigratinib in Children With Achondroplasia (ACH)

NCT05145010 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

NCT04697381 ·Status: COMPLETED ·Phase: PHASE3

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

NCT03989947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia

NCT02055157 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

NCT01009905 ·Status: COMPLETED

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

NCT01110928 ·Status: COMPLETED

Octreotide Efficacy and Safety in First-line Acromegalic Patients

NCT00171886 ·Status: COMPLETED ·Phase: PHASE4

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

NCT00191074 ·Status: COMPLETED ·Phase: PHASE3

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562 ·Status: COMPLETED ·Phase: PHASE2

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

NCT05330325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3